{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:06:33Z","timestamp":1773234393889,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T00:00:00Z","timestamp":1530144000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12886-018-0832-0","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T03:42:23Z","timestamp":1530157343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Highly suspected primary intraocular lymphoma in a patient with rheumatoid arthritis treated with etanercept: a case report"],"prefix":"10.1186","volume":"18","author":[{"given":"Woo Keun","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ah Ran","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Hee","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,28]]},"reference":[{"key":"832_CR1","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/art.21675","volume":"54","author":"E Baecklund","year":"2006","unstructured":"Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F, Catrina AI, et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum. 2006;54:692\u2013701.","journal-title":"Arthritis Rheum"},{"key":"832_CR2","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","volume":"295","author":"T Bongartz","year":"2006","unstructured":"Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA. 2006;295:2275\u201385.","journal-title":"JAMA"},{"key":"832_CR3","first-page":"24","volume":"21","author":"EA Georgakopoulou","year":"2013","unstructured":"Georgakopoulou EA, Andreadis D, Arvanitidis E, Loumou P. Biologic agents and oral diseases--an update on clinical applications. Acta Dermatovenerol Croat. 2013;21:24\u201334.","journal-title":"Acta Dermatovenerol Croat"},{"key":"832_CR4","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2174\/138161207780162926","volume":"1","author":"S Mocellin","year":"2007","unstructured":"Mocellin S, Pilati P, Nitti D. Towards the development of tumor necrosis factor (TNF) sensitizers: making TNF work against cancer. Curr Pharm Des. 2007;1:537\u201351.","journal-title":"Curr Pharm Des"},{"key":"832_CR5","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S0002-9394(14)70828-1","volume":"124","author":"JL Davis","year":"1997","unstructured":"Davis JL, Viciana AL, Ruiz P. Diagnosis of intraocular lymphoma by flow cytometry. Am J Ophthalmol. 1997;124:362\u201372.","journal-title":"Am J Ophthalmol"},{"key":"832_CR6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s10384-012-0150-7","volume":"56","author":"K Kimura","year":"2012","unstructured":"Kimura K, Usui Y, Goto H. Japanese intraocular lymphoma study group. Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma. Jpn J Ophthalmol. 2012;56:383\u20139.","journal-title":"Jpn J Ophthalmol"},{"key":"832_CR7","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.ophtha.2012.11.007","volume":"120","author":"T Missotten","year":"2013","unstructured":"Missotten T, Tielemans D, Bromberg JE, et al. Multicolor flowcytometric immunophenotyping is a valuable tool for detection of intraocular lymphoma. Ophthalmology. 2013;120:991\u20136.","journal-title":"Ophthalmology"},{"key":"832_CR8","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.1167\/iovs.06-0031","volume":"48","author":"N Cassoux","year":"2007","unstructured":"Cassoux N, Giron A, Bodaghi B, et al. IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma. Invest Ophthalmol Vis Sci. 2007;48:3252\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"832_CR9","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.ophtha.2016.01.037","volume":"123","author":"M Costopoulos","year":"2016","unstructured":"Costopoulos M, Touitou V, Golmard JL, et al. ISOLD: a new highly sensitive interleukin score for intraocular lymphoma diagnosis. Ophthalmology. 2016;123:1626\u20138.","journal-title":"Ophthalmology"},{"key":"832_CR10","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ophtha.2014.09.016","volume":"122","author":"M Mehta","year":"2015","unstructured":"Mehta M, Rasheed RA, Duker J, et al. Vitreous evaluation: a diagnostic challenge. Ophthalmology. 2015;122:531\u20137.","journal-title":"Ophthalmology"},{"key":"832_CR11","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1038\/leu.2012.246","volume":"26","author":"AW Langerak","year":"2012","unstructured":"Langerak AW, Groenen PJ, Bruggemann M, et al. EuroClonality\/BIOMED-2 guidelines for interpretation and reporting of Ig\/TCR clonality testing in suspected lymphoproliferations. Leukemia. 2012;26:2159\u201371.","journal-title":"Leukemia"},{"key":"832_CR12","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1167\/iovs.05-0401","volume":"46","author":"SE Coupland","year":"2005","unstructured":"Coupland SE, Hummel M, Muller HH, et al. Molecular analysis of immunoglobulin genes in primary intraocular lymphoma. Invest Ophthalmol Vis Sci. 2005;46:3507\u201314.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"832_CR13","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1634\/theoncologist.2011-0210","volume":"16","author":"CC Chan","year":"2011","unstructured":"Chan CC, Rubenstein JL, Coupland SE, et al. Primary vitreoretinal lymphoma: a report from an international primary central nervous system lymphoma collaborative group symposium. Oncologist. 2011;16:1589\u201399.","journal-title":"Oncologist"},{"key":"832_CR14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3109\/09273940903370755","volume":"17","author":"J Peer","year":"2009","unstructured":"Peer J, Hochberg FH, Foster CS. Clinical review: treatment of vitreoretinal lymphoma. Ocul Immunol Inflamm. 2009;17:299\u2013306.","journal-title":"Ocul Immunol Inflamm"},{"key":"832_CR15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s10792-007-9065-6","volume":"27","author":"JA Gonzales","year":"2007","unstructured":"Gonzales JA, Chan CC. Biopsy techniques and yields in diagnosing primary intraocular lymphoma. Int Ophthalmol. 2007;27:241\u201350.","journal-title":"Int Ophthalmol"},{"key":"832_CR16","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1136\/bjo.2009.167940","volume":"94","author":"S Yeh","year":"2010","unstructured":"Yeh S, Weichel ED, Faia LJ, et al. 25-gauge transconjunctival sutureless vit-rectomy for the diagnosis of intraocular lymphoma. Br J Ophthalmol. 2010;94:633\u20138.","journal-title":"Br J Ophthalmol"},{"key":"832_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/rheumatology\/keq325","volume":"50","author":"W Kievit","year":"2011","unstructured":"Kievit W, Fransen J, Adang EM, den Broeder AA, Bernelot Moens HJ, Visser H, et al. Long-term effectiveness and safety of TNF-blocking agents in daily clinical practice: results from the Dutch rheumatoid arthritis monitoring register. Rheumatology (Oxford). 2011;50:196\u2013203.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"832_CR18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1136\/annrheumdis-2016-209389","volume":"76","author":"LK Mercer","year":"2017","unstructured":"Mercer LK, et al. Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology biologics register for rheumatoid arthritis. Ann Rheum Dis. 2017 Mar;76(3):497\u2013503.","journal-title":"Ann Rheum Dis"},{"key":"832_CR19","doi-asserted-by":"crossref","unstructured":"Bongartz T, Sutton AJ, Sweeting MJ, et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA. 2006;295(19):2275-85.","DOI":"10.1001\/jama.295.19.2275"},{"key":"832_CR20","doi-asserted-by":"crossref","unstructured":"Lopez-Olivo MA, Tayar JH, Martinez-Lopez JA, et al. Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis. JAMA. 2012;308(9):898-908.","DOI":"10.1001\/2012.jama.10857"},{"issue":"3","key":"832_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1159\/000440646","volume":"6","author":"K Nagata","year":"2015","unstructured":"Nagata K, Inaba T, Kinoshita S. CD5-positive primary intraocular B-cell lymphoma arising during methotrexate and tumor necrosis factor inhibitor treatment. Case Rep Ophthalmol. 2015;6(3):301\u20136.","journal-title":"Case Rep Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-018-0832-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-018-0832-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-018-0832-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T23:07:05Z","timestamp":1561676825000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-018-0832-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,28]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["832"],"URL":"https:\/\/doi.org\/10.1186\/s12886-018-0832-0","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,28]]},"assertion":[{"value":"4 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study complied with the tenets of the Declaration of Helsinki. This report was determined to be exempt from IRB review by the Institutional Review Board of Asan Medical Center.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from the patient for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The Authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"156"}}